awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35744973-F0166A17-F1ED-4F54-B365-6ABC101AB10A
Q35744973-F0166A17-F1ED-4F54-B365-6ABC101AB10A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35744973-F0166A17-F1ED-4F54-B365-6ABC101AB10A
HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy.
P2860
Q35744973-F0166A17-F1ED-4F54-B365-6ABC101AB10A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35744973-F0166A17-F1ED-4F54-B365-6ABC101AB10A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
664645ff73647addda54fa8dd844ffe80827386a
P2860
Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601).